巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Krystal Biotech

    KRYS
    73.100
    1.810
    2.54%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Krystal Biotech - 延遲價格・最後更新於 06/07 6:16
    最高位
    76.300
    最低位
    72.000
    開市價
    --
    前收市價
    71.290
    成交量(千)
    6.95
    成交額(百萬)
    4.57
    買入
    72.950
    賣出
    73.480
    每手股數
    --
    市值(百萬)
    1,873.93
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    102.990 - 38.856
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Krystal Biotech
    證券代碼
    KRYS.US
    所屬板塊
    Biotechnology
    公司業務
    Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future.
    發行量
    25635138
    公司總部
    2100 Wharton Street, Suite 701
    公司網址
    https://www.krystalbio.com
    公司電郵
    inquiries@krystalbio.com
    公司電話
    +1 412 586-5830
    暫無內容

    關於

    Krystal Biotech(KRYS.US)所屬的行業板塊為Biotechnology。
    Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future.
    詳細公司背景可參考: https://www.krystalbio.com